Chronic Migraine Epidemiology and Outcomes Study

N/ACompletedNCT01648530

Allergan16,789 enrolled

Overview

This is a population internet-based study to characterize migraine clinical course and impact on family.

Study Type

OBSERVATIONAL

Enrollment

16,789

Conditions

Migraine Disorders

Interventions

No TreatmentOTHER

No Treatment

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * History of migraine * U.S. Member of Survey Panel * Household member of study participant * Ability to complete internet-based questionnaires Exclusion Criteria: * No access to internet

Outcomes

Primary Outcomes

Percentage of Participants With Episodic Migraine (EM) or Chronic Migraine (CM)

EM is defined as \<15 headache days/month and CM is defined as ≥15 headache days/month.

Time frame: Baseline

Migraine Disability Assessment (MIDAS)

The Midas score is a patient completed 5-item questionnaire about lost time and productivity (for work, school or family/social activities) in the past 3 months (number of days missed) where: 0-5=Little or No disability, 6-10=Mild disability, 11-20=Moderate disability or 21+ Severe disability. The Midas scores assessed at Months 3, 6, 9 and 12 were averaged.

Time frame: 12 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.